175 related articles for article (PubMed ID: 16920248)
21. Cervicovaginal cytology in the detection of recurrence after cervical cancer treatment.
Rimel BJ; Ferda A; Erwin J; Dewdney SB; Seamon L; Gao F; DeSimone C; Cotney KK; Huh W; Massad LS
Obstet Gynecol; 2011 Sep; 118(3):548-553. PubMed ID: 21860282
[TBL] [Abstract][Full Text] [Related]
22. Cervicovaginal smear abnormalities in sexually active adolescents. Implications for management.
Simsir A; Brooks S; Cochran L; Bourquin P; Ioffe OB
Acta Cytol; 2002; 46(2):271-6. PubMed ID: 11917572
[TBL] [Abstract][Full Text] [Related]
23. Cost--effectiveness of pap smear in Kermanshah, Iran.
Nokiani FA; Akbari H; Rezaei M; Madani H; Ale Agha ME
Asian Pac J Cancer Prev; 2008; 9(1):107-10. PubMed ID: 18439087
[TBL] [Abstract][Full Text] [Related]
24. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests.
Elsheikh TM; Kirkpatrick JL; Wu HH
Cancer; 2006 Oct; 108(5):277-81. PubMed ID: 16937376
[TBL] [Abstract][Full Text] [Related]
25. Distribution of human papillomavirus types in ThinPrep Papanicolaou tests classified according to the Bethesda 2001 terminology and correlations with patient age and biopsy outcomes.
Evans MF; Adamson CS; Papillo JL; St John TL; Leiman G; Cooper K
Cancer; 2006 Mar; 106(5):1054-64. PubMed ID: 16421920
[TBL] [Abstract][Full Text] [Related]
26. Changing spectrum of squamous cell abnormalities observed on papanicolaou smears in Mubarak Al-Kabeer Hospital, Kuwait, over a 13-year period.
Kapila K; George SS; Al-Shaheen A; Al-Ottibi MS; Pathan SK; Sheikh ZA; Haji BE; Mallik MK; Das DK; Francis IM
Med Princ Pract; 2006; 15(4):253-9. PubMed ID: 16763390
[TBL] [Abstract][Full Text] [Related]
27. Frequency of cervical smear abnormalities within 3 years of normal cytology.
Sawaya GF; Kerlikowske K; Lee NC; Gildengorin G; Washington AE
Obstet Gynecol; 2000 Aug; 96(2):219-23. PubMed ID: 10908766
[TBL] [Abstract][Full Text] [Related]
28. Conventional Pap smear and liquid-based cytology as screening tools in low-resource settings in Latin America: experience of the Latin American screening study.
Longatto-Filho A; Maeda MY; Erzen M; Branca M; Roteli-Martins C; Naud P; Derchain SF; Hammes L; Matos J; Gontijo R; Sarian LO; Lima TP; Tatti S; Syrjänen S; Syrjänen K
Acta Cytol; 2005; 49(5):500-6. PubMed ID: 16334026
[TBL] [Abstract][Full Text] [Related]
29. Do health care providers have a lower prevalence of abnormal pap smears than the general public?
Suwannarurk K; Bhamarapravatana K; Kheolamai P; Thaweekul Y; Mairaing K; Poomtavorn Y; Pattaraarchachai J
J Med Assoc Thai; 2010 Dec; 93 Suppl 7():S114-9. PubMed ID: 21294405
[TBL] [Abstract][Full Text] [Related]
30. Genetic damage in exfoliated cells of the uterine cervix. Association and interaction between cigarette smoking and progression to malignant transformation?
Cerqueira EM; Santoro CL; Donozo NF; Freitas BA; Pereira CA; Bevilacqua RG; Machado-Santelli GM
Acta Cytol; 1998; 42(3):639-49. PubMed ID: 9622681
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the SurePath liquid-based Papanicolaou smear with the conventional Papanicolaou smear in a multisite direct-to-vial study.
Fremont-Smith M; Marino J; Griffin B; Spencer L; Bolick D
Cancer; 2004 Oct; 102(5):269-79. PubMed ID: 15386329
[TBL] [Abstract][Full Text] [Related]
32. Opportunistic testing of medically underserved women for cervical cancer in South Africa.
van Bogaert LJ; Knapp DC
Acta Cytol; 2001; 45(3):313-6. PubMed ID: 11393060
[TBL] [Abstract][Full Text] [Related]
33. [Factors associated with abnormal cervical cytology in pregnant women].
Fan L; Zou LY; Wu YM; Zhang WY
Zhonghua Fu Chan Ke Za Zhi; 2010 Feb; 45(2):109-13. PubMed ID: 20420780
[TBL] [Abstract][Full Text] [Related]
34. Comparison of visual inspection with acetic acid and cervical cytology to detect high-grade cervical neoplasia among HIV-infected women in India.
Sahasrabuddhe VV; Bhosale RA; Kavatkar AN; Nagwanshi CA; Joshi SN; Jenkins CA; Shepherd BE; Kelkar RS; Sahay S; Risbud AR; Vermund SH; Mehendale SM
Int J Cancer; 2012 Jan; 130(1):234-40. PubMed ID: 21387289
[TBL] [Abstract][Full Text] [Related]
35. [Atypical glandular cells (AGC) on Papanicolaou smears--the great challenge of cervix screening programs].
Schneider F; Mágori A; Orosz Z; Pulay T
Orv Hetil; 2005 Oct; 146(44):2239-46. PubMed ID: 16302355
[TBL] [Abstract][Full Text] [Related]
36. The IMproving Primary Screening And Colposcopy Triage trial: human papillomavirus, cervical cytology, and histopathologic results from the baseline and 1-year follow-up phase.
Safaeian M; Wright TC; Stoler MH; Ranger-Moore J; Rehm S; Aslam S; Fang Q; Volkir P; Ridder R
Am J Obstet Gynecol; 2021 Sep; 225(3):278.e1-278.e16. PubMed ID: 33852886
[TBL] [Abstract][Full Text] [Related]
37. Critical Analyses of the Introduction of Liquid-Based Cytology in a Public Health Service of the State of São Paulo, Brazil.
Longatto-Filho A; Levi JE; Martins TR; Cohen D; Cury L; Villa LL; Eluf-Neto J
Acta Cytol; 2015; 59(3):273-7. PubMed ID: 26279162
[TBL] [Abstract][Full Text] [Related]
38. Significance of high-risk human papillomavirus DNA detection in women 50 years and older with squamous cell papanicolaou test abnormalities.
Zhao C; Zhao S; Heider A; Austin RM
Arch Pathol Lab Med; 2010 Aug; 134(8):1130-5. PubMed ID: 20670132
[TBL] [Abstract][Full Text] [Related]
39. Liquid-based cytology versus conventional Papanicolaou smear in an organized screening program : a prospective randomized study.
Strander B; Andersson-Ellström A; Milsom I; Rådberg T; Ryd W
Cancer; 2007 Oct; 111(5):285-91. PubMed ID: 17724676
[TBL] [Abstract][Full Text] [Related]
40. Manual liquid based cytology in primary screening for cervical cancer--a cost effective preposition for scarce resource settings.
Nandini NM; Nandish SM; Pallavi P; Akshatha SK; Chandrashekhar AP; Anjali S; Dhar M
Asian Pac J Cancer Prev; 2012; 13(8):3645-51. PubMed ID: 23098448
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
